CHU Clermont-Ferrand
Clermont-Ferrand, France
NCT Number: NCT05684939
Pain is one of the most prevalent symptoms during and after cancer. Pain can be the consequence of several situations (disease progression, surgery, and anticancer drugs). However, pain can frequently be associated with a substance use disorder (alcohol, tobacco, drugs, and illicit products such as cannabis). The relationship between substance use and pain is known to be complex and interdependent, i.e. pain can reinforce substance use and substance use can promote pain. However, few data in the literature are available on the use of psychoactive substances in relation to pain in the context of cancer (cancer patients and cancer survivors). Moreover, the scientific literature agrees on the fact that these elements are little studied and underestimated in the clinic.
The investigators hypothesize that, in cancer patients or cancer survivors, the prevalence of the use of psychoactive substances would be higher in the presence of pain, and would be associated with its intensity and its impact on the quality Health-Related Living (HRQoL).
The main objective of this study will be to compare, in an adult population of patients suffering from cancer or having had cancer, the prevalence of the consumption of psychoactive substances in painful patients compared to non-painful patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Clermont-Ferrand, France
Patients will answer to an online questionnaire thanks to associations of cancer patients and social networks, in order to explore their substance use and pain status.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Online self-administered questionnaire exploring substance use, pain, chemotherapy-induced peripheral neuropathy, health-related quality of life, anxiety, depression, social and material deprivation, patients and oncological charactericitcs, and intercurrent pathologies
Time frame: day 1
Legal: alcohol, tobacco, electronic cigarette, psychotropic drugs (benzodiazepines, z-drugs, and opioids), CBD, and other susbtances Illegal: cannabis, and other drugs
At least once in the past year, at least once in the past month, at least once in the past week, or at least once a day
Time frame: day 1
Brief pain inventory
Time frame: day 1
DN4 interview questionnaire
Time frame: day 1
Ongoing analgesic drugs
Time frame: day 1
QLQ-CIPN20 questionnaire
Time frame: day 1
QLQ-C30 questionnaire
Time frame: day 1
HADS questionnaire
Time frame: day 1
EPICES questionnaire
Time frame: day 1
age, sex, height, weight, body mass index, area of residence (urban or rural), socio-professional status (INSEE), and department
Time frame: day 1
type of cancer, date of cancer diagnosis, and type of treatment (received and/or ongoing)
Time frame: day 1
open question
University Hospital, Clermont-Ferrand
Other
Study of the Relation Between the Consumption of Psychoactive Substances and Pain, in Patients Suffering or Surviving From Cancer and Followed in France: Cross-sectional Pilot Study
Acronym: CAPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03847753
Acquired Immunodeficiency Syndrome, Allergy
View Trial DetailsNCT05643027
Cancer, Chemically-Induced Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT05869604
Behavior, Cancer
Durham, North Carolina, United States
View Trial DetailsNCT00646945
Cancer, Neoplasms
Vandœuvre-lès-Nancy, France
View Trial Details